CDSCO approves India’s first dengue vaccine Qdenga for individuals aged 4–60 years Takeda's recombinant live attenuated tetravalent dengue vaccine receives marketing authorisation for dengue prevention in India
USAID and Takeda launch Dengue prevention campaign The campaign in the launch phase will focus on educating school children and communities across Maharashtra, Odisha and Uttar…
